Product Highlight Announcement
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel. This designation certifies that the DRG ELISA meets the performance target set by DEQAS for 25 Hydroxyvitamin D.
DRG is committed to bringing to market the best, most accurate tests, and as such, we would like to present the specifications and indications of our 25-OH Vitamin D total ELISA (EIA-5396) testing kit.
Vitamin D deficiency is a serious issue that can affect people at any age. Without enough sunlight and dietary Vitamin D, children may be at greater risk for rickets and adults may be at greater risk for osteoporosis. While issues in bone development and strength are what first come to mind with Vitamin D deficiency, it has been shown that it may raise the risk of high blood pressure and type 2 diabetes.
Beyond the most commonly studied effects of Vitamin D deficiency, there are a wide-range of other health issues that are currently being researched as being directly impacted by Vitamin D deficiency and lack of absorption, including:
- Some types of cancer
- Hypertension (high blood pressure)
- Autoimmune conditions (such as lupus, ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis)
- PCOS (polycystic ovarian syndrome)
- Diabetes mellitus (both types 1 and 2)
DRG offers the 25-OH Vitamin D total ELISA (EIA-5396), approved for laboratory research use only in the United States, and is not for use in diagnostic or therapeutic procedures. However, this product has received its CE Mark.
This DRG Elisa is an enzyme immunoassay for measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in serum and plasma.
Specifications of the product include:
- Serum/ Plasma testing
- Only 25 uL sample required
- Kit-internal controls
- Wells single-breakable
- Very simple assay procedure
- 105 min incubation time
- No extraction step required
Latest posts by Gregory C. Guest (see all)
- DRG´s Newly Optimized Salivary Testosterone Kit used in New Study! - September 18, 2017
- DRG TM-CA 72-4 ELISA Kit used in NYU Winthrop Hospital Cancer Study! - July 26, 2017
- DRG Attends ASM 2017 in New Orleans! - June 13, 2017
News and Updates
New Poster presented using DRG´s newly optimized Salivary Testosterone Kit Ellie Shuo Jin, Doctoral Candidate in Clinical Psychology of the University of Texas at Austin, presented her poster at the Meeting of International Society of Psychoneuroendocrinology...read more
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more